Phase II trial of thalidomide in renal-cell carcinoma.
Escudier B, Lassau N, Couanet D, Angevin E, Mesrati F, Leborgne S, Garofano A, Leboulaire C, Dupouy N, Laplanche A.
Escudier B, et al. Among authors: dupouy n.
Ann Oncol. 2002 Jul;13(7):1029-35. doi: 10.1093/annonc/mdf213.
Ann Oncol. 2002.
PMID: 12176780
Free article.
Clinical Trial.